glaucoma research
DESCRIPTION
Glaucoma Research. Boosting optic nerve energy to slow glaucoma Ian Trounce Principal Investigator CERA Wagstaff Fellow RVEEH. The burden of glaucoma. 67 million world-wide 6 million estimated blind 7 million out-patient visits in the USA 150,000 people in Australia - PowerPoint PPT PresentationTRANSCRIPT
Glaucoma ResearchBoosting optic nerve energy to slow glaucoma
Ian TrouncePrincipal Investigator CERAWagstaff Fellow RVEEH
The burden of glaucoma• 67 million world-wide
• 6 million estimated blind
• 7 million out-patient visits in the USA
• 150,000 people in Australia
• $145 million in direct health costs to Australia
• Significant number of Australians with glaucoma are
undiagnosed.
• Eye pressure lowering is the only treatment proven to be effective in glaucoma
• Lowering eye pressure does not always prevent progression
• Cannot restore optic nerve tissue once lost
Problems with current treatments
• Professor Jonathan Crowston, Principal Investigator• Translational research
– Molecular and cellular research– Experimental models
• Rodents, rabbits– Clinical research
Glaucoma Research Unit
• ‘Burns’ fuels (food)• Produces energy (ATP)• Produces byproduct
‘free radicals’• Wears out with age
The cell’s powerhouse: The mitochondrion
Mitochondria: Power generators of our cells
IN:
Fuel•Carbohydrates•Fats•Proteins•O2
OUT:
Energy (ATP)Free radicalsCO2
H20Heat
Mitochondrial DNA- Maternal inheritance
Douglas C. Wallace – University of Pennsylvania
Complex I defect in glaucoma- Link to Parkinson’s disease?- Is it mitochondrial DNA-linked?- New collaboration with Doug Wallace, Univ. Pennsylvania
The optic nerve- Glaucoma
Dopamine neurons- Parkinson’s disease
Highly energetic nerve cells with long axonsare prone to age-related decline
Exercise (and fasting) allow old optic nerves to recover from a pressure injury
2.25 cd.s/m2 3.0 cd.s/m2
P=0016 P=0.0014
PhNR change at 1 month
IOVS 2013
Mitochondrial energy generation is impaired in some glaucoma patients
Diet moderation and exercise improve optic nerve resilienceIs this due to increased mitochondrial ‘health’?
Genetic analysis of mitochondrial DNA in glaucoma subjects underwayCan we identify subjects with genetic markers who may respondto ‘mitochondrial boosting’ therapies?
Summary
Can we drive increased Mitochondrial turnover to “recharge the batteries”
Dietary restriction
Exercise
Resveratrol
Other drugse.g.FibratesMetforminRapamycin
Thank you
FundingWagstaff Bequest (RVEEH)DHB Foundation Brockhoff Foundation (ANZ Trustees) – Leber Optic Atrophy stem cell studyMason Foundation (ANZ Trustees) – The ‘good’ Alzheimer protein & the ageing eyeMichael J. Fox Foundation for Parkinson’s disease – A mitochondrial PD modelNational Health and Medical Research Council